Â鶹´«Ã½Ó³»­

20240105-suicidal.jpg

Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes

January 5, 2024 — NIH-funded analysis finds patients treated with semaglutide had 49% to 73% lower risk of suicidal ideation than those given other medications.